Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
about
Treating prediabetes with metformin: systematic review and meta-analysisRestoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivityInsulin and atherosclerosis: villain, accomplice, or innocent bystander?Medical care from childhood to adulthood in type 1 and type 2 diabetes.Insulin sensitizers may attenuate lean mass loss in older men with diabetesRecombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes.A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.Metformin.Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction?Changes in physical performance in older women according to presence and treatment of diabetes mellitus.Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.Metabolic effects of metformin in patients with impaired glucose tolerance.Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus.Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification?Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions.Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration - A Mass Spectrometry Imaging Study of the Perfused Rat Liver.Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese.Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.Insulin and polycystic ovary syndrome: a new look at an old subject.ATP-sensitive K(+) Channels in the Regulation of Feeding Behavior: A Hypothesis.
P2860
Q24642274-BA813921-D917-4060-89BF-0EEFF5AD2296Q30476616-153D6C9E-E59A-4B5F-9D64-8390C36CC908Q33612890-26E68C9E-B1BC-4929-9DF1-3BDAF17E1B52Q34444323-96E5339B-A160-4D8F-B33D-FD5AAF94406DQ35408045-95179498-58F0-4A72-B55F-91BD874913E8Q35796963-59F8EDA9-96FF-4B38-BD40-7C2F914B7632Q36596873-2EF89E54-C409-425D-8FD3-91D694C08671Q37083602-D9F9BC72-62B4-4CE6-9DB3-0C9066B7BF22Q37157528-7BD4E3C5-FFFD-4BB1-A8F3-B5F4D7C33127Q37267260-8E553CC2-7E08-4BE9-8F86-FC2AC74FA8E9Q37307513-D58AB2DF-F8E3-47D0-9190-E0618540733AQ40623938-4D3A060B-27AF-4F14-9567-35A9F783DEE0Q43734822-7AB3C942-6163-444F-89D8-25F9B7B0417FQ44822479-B69D2A41-086B-49AE-9645-606DD85CCB42Q47332159-A569F24A-E110-4A5D-A635-8EFB242FBDDEQ47769777-8EE3CB48-4E4C-45A0-984F-D0CF9EF2067DQ50420259-2E58DC83-0E32-438B-8A4B-911C40D69D64Q51249819-C3AC486D-71A0-486B-ABF2-A3C2ADF0FFDAQ51563846-4BC1D787-BBC0-4AC2-8F72-DB254BD0C2E4Q51593183-D563F819-FF48-49D6-BB5B-671D400AA786Q54118805-12F56E91-14EA-4012-A05A-6FB0FDF214D1Q54173930-19C0FBDC-4C8E-4ACA-BEEF-CFF7E34EC808
P2860
Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@en
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@nl
type
label
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@en
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@nl
prefLabel
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@en
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@nl
P2093
P921
P356
P1433
P1476
Metformin normalizes nonoxidat ...... atives of patients with NIDDM.
@en
P2093
P304
P356
10.2337/DIAB.41.3.354
P407
P577
1992-03-01T00:00:00Z